Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25368206 | 1.00 | MMP2 (0.41) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL29930727 | 1.00 | MMP2 (0.41) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL19744398 | 0.83 | MMP2 (0.54) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL29260191 | 0.83 | MMP2 (0.54) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL21682451 | 0.83 | MMP2 (0.54) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL18339420 | 0.83 | MMP2 (0.54) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL19744399 | 0.83 | MMP2 (0.54) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL28205851 | 0.81 | MMP2 (0.38) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL25369568 | 0.81 | HSD17B10 (0.43) | MMP2ANPEPDPP7DPP8DPP9 | |
| SCHEMBL29072306 | 0.81 | HSD17B10 (0.43) | MMP2ANPEPDPP7DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119868377-A | Combination therapy for the treatment of cancer | 阿斯利康(瑞典)有限公司 | 2025-04-25 | — | — | CN | disclosed |
| EP-4054591-A1 | COMBINATION THERAPY FOR TREATING CANCER | Astrazeneca AB (SE) | 2022-09-14 | — | — | EP | disclosed |